To The Moon, Untraced.

To The Moon began as a tag. Gazoo, a Montserrat-born artist working out of Bushwick, put "TO THE MOON↑" on walls in New York, Los Angeles, Atlanta and Miami; Brooklyn Street Art, Bushwick Daily and Greenpointers were covering him by 2016. His own explanation of the phrase, given to Greenpointers, is disarmingly plain: "to the moon is really all about motivating people and just like reach for your goals." The cannabis brand that carries the tag now sells flower in reusable spray cans across every borough, Westchester, Long Island and Buffalo.

It is a good story and, unusually for this series, the art half of it is independently documented rather than asserted. We could not verify the 2012 founding date — every instance of it traces to brand copy, and the earliest third-party coverage of Gazoo we found is 2016 — but the artist, the tag and the trajectory are real.

The chemistry is where it gets interesting, and it divides in a way we have not seen before. On the menus that publish terpene data, the data is good: full detection lists that sum exactly to their stated totals, minor cannabinoids most brands drop, and THC figures that survive an arithmetic check. This is not a brand fabricating numbers.

It is a brand publishing numbers that cannot be traced to anything. Across the brand's own sites, Leafly, Weedmaps and more than a dozen dispensary menus, we found the following:

New York requires a scannable code on every retail package linking to a downloadable certificate. Whether the physical cans carry a compliant code is something we could not test remotely and are not asserting either way. What we can say is that no certificate is reachable through any digital surface this brand or its retailers maintain, and that flower.uptothemoon.com — the obvious home for one — currently returns "Under Construction. Site is undergoing maintenance."

What is published, and it is worth crediting.

Six cultivars carry quantified terpene panels: five on Terp Bros NYC's menu in Astoria, two on The Daily Green in Times Square. Terp Bros publishes the more complete data and deserves the credit for it as much as the brand does.

Terp Bros NYC and The Daily Green menus · 3.5g $35.40 · 14g $88.50 · no lab, batch or date on any listing

The most useful thing in the data.

Sort the six panels by potency and a clean inverse relationship appears, and it is the single most practical finding in this piece.

The lower-potency flower in this catalogue carries 1.94× the terpene content of the higher-potency flower. Guavatron at 23.82% THC delivers 1.70% terpenes; Cookies & Cream at 30.48% delivers 0.44%. On the terpene-to-THC ratio we introduced in Volume 07, that is 1:14.0 against 1:69.3 — a fivefold difference in aromatic mass per unit of potency, inside one brand, on one shelf, at the same price.

This is the trade-off the entire high-THC shelf is built on, and it is rarely this visible. A buyer choosing To The Moon by the number on the front of the can is systematically selecting against the compounds that determine how the flower actually smells and behaves. The two SKUs we would actually recommend from this catalogue — Guavatron and Big Applato, both limonene-led at over 40% of terpene mass — are the two a potency shopper would walk past.

The edibles are compliant and undocumented.

Eight gummy SKUs, all identical in architecture: 5 mg THC per piece, 20 pieces, 100 mg per package. Pluto Punch, Cherry Nova, Space Unicorn, Electric Lemonade, Strawberry Spacejam, Mystery Moon, Astro Apple, The Grape Gazoo. Against New York's caps of 10 mg per serving and 100 mg per package, that is half the serving ceiling and exactly the package ceiling. Compliant, and a sensible low-dose format.

What is published about them, in total: the THC figure and the words "gluten-free and vegan." No ingredient list. No minor cannabinoids. No certificate. No per-piece verification of any kind. After nine volumes of this series — after RIVR published every milligram and Eaton published a per-piece panel for every botanical — a 100 mg edible whose entire composition disclosure is two dietary adjectives is a conspicuous outlier.

Two claims on a retailer page, tested.

The nano-emulsion and onset claims appear on Kaya Bliss Dispensary's brand page — a retailer surface, not one the brand controls — and we found them nowhere else. We test them here because they are what a shopper searching this brand will find.

Who actually makes this.

To The Moon is not a New York licensee. We queried the state's licensee dataset for the brand name, for variants, and for every entity containing "moon." No record matches. Like several brands in this series, it is produced under somebody else's licence — which is ordinary and legal, and in this case leads somewhere that a reader deserves to know about.

Leafly's brand page names the licence: OCM-PROC-24-000047. In the OCM dataset that number resolves to Omnium Health Inc., doing business as Omnium Canna, an Adult-Use Processor (Type 1, Extracting) in Suffolk County, issued 17 June 2024. The dataset currently lists that licence as Inactive, expired, and Non-Operational.

Omnium is the respondent in the largest licence-integrity action New York's Office of Cannabis Management has brought.

There is one further open question we could not close. The licence at OCM-PROC-24-000047 is expired and marked Non-Operational, yet To The Moon product is on shelves today. Either Leafly's attribution is stale, or production has moved to an entity we could not identify. We put that question to the brand before publication and will print the answer.

We raise all of this in a chemistry review for one reason, and it is not editorial appetite. OCM's own exhibit in the Omnium matter was "no batch ID/traceability." The defining characteristic of this brand's published chemistry — across every menu, every format, every surface — is no batch ID and no traceability. Those are the same property, described once by a regulator and once by us, arrived at independently.

A namesake problem readers should know about.

Several unlicensed mail-order websites sell products branded "TO THE MOON" at 1,000 mg per package, 100 mg per piece, from around $80, with offers of free shipping to all fifty states and no medical card required. One also lists a "TO THE MOON DESIGNER FLOWER IN SPRAY CAN."

A 100 mg-per-piece edible is ten times New York's per-serving cap and ten times its per-package cap. It cannot lawfully be a New York adult-use product. Whether this is licensed product diverted into grey-market channels, outright counterfeit, or an unrelated hemp-side namesake, we could not determine and are not going to guess.

What a batch code is for.

Ten volumes in, the thing we keep finding is not fraud. It is absence. FK+ disclosed no botanical dose. Green Lightning published totals nobody could reconstruct. Silly Nice let its pages drift from its paperwork. In almost every case the underlying product was fine and the documentation was the failure.

To The Moon is the purest version of that pattern we have examined. The numbers it publishes are, as far as we can test them, correct — internally consistent, arithmetically sound, and more complete on some SKUs than several better-regarded brands manage. There is no evidence anywhere in this analysis that the brand is misrepresenting its chemistry.

And none of it can be checked, because a number without a batch is a number without a referent. It describes some flower, tested at some point, by someone. It cannot describe the jar in your hand. That is what a batch code is for, and it is the entire distance between a figure a customer can rely on and a figure a customer has to take on faith.

A regulator has already said the same thing about this supply chain, in almost the same words, with subpoena power behind it. We will revise this piece the day a certificate library appears.